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Open access under the Ela b s t r a c t
Nitrosyl ruthenium complexes are promising NO donor agents with numerous advantages for the bio-
logic applications of NO. We have characterized the NO release from the nitrosyl ruthenium complex
[Ru(NO2)(bpy)2(4-pic)]
+ (I) and the reactive oxygen/nitrogen species (ROS/RNS)-mediated NO actions
on isolated rat liver mitochondria. The results indicated that oxidation of mitochondrial NADH promotes
NO release from (I) in a manner mediated by NO2 formation (at neutral pH) as in mammalian cells, fol-
lowed by an oxygen atom transfer mechanism (OAT). The NO released from (I) uncoupled mitochondria
at low concentrations/incubation times and inhibited the respiratory chain at high concentrations/incu-
bation times. In the presence of ROS generated by mitochondria NO gave rise to peroxynitrite, which, in
turn, inhibited the respiratory chain and oxidized membrane protein–thiols to elicit a Ca2+-independent
mitochondrial permeability transition; this process was only partially inhibited by cyclosporine-A,
almost fully inhibited by the thiol reagent N-ethylmaleimide (NEM) and fully inhibited by the NO scav-
enger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO). These actions corre-
lated with the release of cytochrome c from isolated mitochondria as detected by Western blotting
analysis. These events, typically involved in cell necrosis and/or apoptosis denote a potential speciﬁc
action of (I) and analogs against tumor cells via mitochondria-mediated processes.
 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Mitochondria are both sources and targets of nitric oxide (NO),
derivative reactive nitrogen species (RNS) such as peroxynitrite
and reactive oxygen species (ROS) in general [1,2]. Depending on
the concentration and exposure time NO can either promote or
inhibit cell death; in the latter case, NO may contribute to carcino-
genesis [3,4]. At relatively low concentrations (0.1–100 nM), the
NO generated by nitric oxide synthases works as key signal in
many cellular mechanisms [2,5,6]; however, at relatively high con-
centrations (above 1 lM), NO is cytotoxic [5]. Therefore, select con-
centrations of agents that release NO at speciﬁc targets may trigger
death of speciﬁc cells and present potential applications in cancer
therapy [7,8].
Classical NO derivatives such as organic nitrites and nitroprus-
side still present severe restrictions on therapeutic use due to their
photochemical instability and toxicity [9,10]. The object of thissevier OA license.study was a ruthenium metal complex that is able to capture
NO [11,12] to yield the nitrosyl ruthenium complex [Ru(NO2)(b-
py)2(4-pic)]+ (I). (I) belongs to a particular class of NO donor com-
pounds whose members have widely studied structures and
chemical/photochemical reactivity [13–16]; these compounds
release NO via reduction reactions [17] and light irradiation [16].
However the biologic activities and potential applications of mem-
bers of this class of NO donors have not been reported.
Mitochondria are able to facilitate the release of NO from nitro-
syl ruthenium complexes because they are sources of reducing
agents such as NADH [17]. The reducing capacity of mitochondria
with respect to this type of compounds, as well as some effects of
NO release on these organelles was previously reported [17,18].
Moreover, our preliminary study on the stability of (I) revealed
the presence of nitrite (NO2) in the structure of the complex at
neutral pH, so we hypothesized that NO release occurs via an oxy-
gen atom transfer mechanism (OAT) [19]. Also in mammalian cells
NO2 is an intermediary which is reduced to NO through a reaction
that employs electron-donor systems such as NAD(P)H [20,21]. In
this context, we characterized the NO release from (I) and its
F.P. Rodrigues et al. / Nitric Oxide 26 (2012) 174–181 175ROS/RNS-mediated actions on mitochondria, emphasizing the
involvement of the mitochondrial NADH oxidation/OAT mecha-
nism in the NO release and the opening of permeability transition
pores (PTPs) in the NO action. PTP opening involves the oxidation
of mitochondrial membrane protein–thiols by ROS/RNS and is
implicated in the release of cytochrome c from mitochondria,
which is, in turn, associated with cell death induction.Materials and methods
Synthesis of [Ru(NO2)(bpy)2(4-pic)]
+(I)
The nitrosyl ruthenium complex (I) was prepared by dissolving
[RuNO(bpy)2(4-pic)](PF6)3, synthesized as previously reported
[22], in an aqueous solution at pH 7.4. The aqua-bound specie,
cis-[Ru(H2O)(bpy)2(4-pic)]2+ complex, used as control of the
complex (without NO), was synthesized in solution by reducing
[RuNO(bpy)2(4-pic)]3+ through controlled potential electrolysis at
0.6 V vs Ag/AgCl, in 0.01 M phosphate buffer solution pH 7.4
[22]. Complexes were characterized by UV–visible spectroscopy
and the results were compared to their previously described prop-
erties [22].
Isolation of rat-liver mitochondria
Mitochondria were isolated by standard differential centrifuga-
tion [23]. Male Wistar rats weighing approximately 200 g were
sacriﬁced by decapitation, according to research protocols ap-
proved by the CEUA-USP Rib. Preto; livers (10–15 g) were immedi-
ately removed, sliced in medium (50 ml) consisting of 250 mM
sucrose, 1 m Methyleneglycol-bis(b-aminoethyl)-N,N,N0,N0-tetra-
acetic acid (EGTA) and 10 mM 4-(2-hydroxyethyl)-1-piperazinee-
thanesulfonic acid (HEPES)–KOH, pH 7.2, and homogenized three
times for 15 s at 1 min intervals using a Potter–Elvehjem homoge-
nizer. Homogenates were centrifuged (580g, 5 min), and the result-
ing supernatant was further centrifuged (10300g, 10 min). The
pellets were then suspended in medium (10 ml) consisting of
250 mM sucrose, 0.3 mM EGTA and 10 mM HEPES–KOH, pH 7.2,
and centrifuged (3400g, 15 min). The ﬁnal mitochondrial pellet
was suspended in medium (1 ml) consisting of 250 mM sucrose
and 10 mM HEPES–KOH, pH 7.2, and used within 3 h. Mitochon-
drial protein contents were determined by the Biuret reaction.
For assays, mitochondria were energized with 5 mM potassium
succinate (plus 2.5 lM rotenone) in a standard medium consisting
of 125 mM sucrose, 65 mM KCl and 10 mM HEPES–KOH, pH 7.4, at
30 C.
Direct detection of NO release from (I)
NO release from (I) (50 lM) after incubation with succinate-
energized mitochondria (1 mg protein/ml) in the standard medium
was assessed through a Selective Sensor Electrode (AmiNO 700) in
the dark. NO release was also assessed in the absence of mitochon-
dria but in the presence of added b-NADH (1 mM), as well as in the
presence of NaNO2 (10 lM).
Assessment of superoxide generated by the xanthine/xanthine oxidase
(X/XO) reaction
Superoxide generated by the X/XO reaction was assessed by
measuring the absorption at 560 nm due to the nitro blue tetrazo-
lium (NBT) reduction in a reaction mixture containing 10–100 lM
(I), 80 lM sodium pyrophosphate buffer pH 7.5, 120 lM xanthine
(X), 0.1 U/ml xanthine oxidase (XO) and 100 lM NBT [24]. The
interaction between the NO released from (I) and the superoxidegenerated by the X/XO reaction was assessed both in the presence
of mitochondria and under photo-irradiation of the complex.
Assessment of protein–thiols
Mitochondrial membrane protein–thiols remaining after the
oxidation were assessed with 5,5-dithiobis(2-nitrobenzoic)acid
(DTNB, Ellman’s reagent) as previously described [25]. The mito-
chondrial suspension was incubated brieﬂy in the standard med-
ium, submitted to three subsequent freeze–thawing procedures
to release matrix proteins and then centrifuged for 2 min at
6708g in a 5415 C Eppendorf Centrifuge (Eppendorf-5 Prime, Inc.,
Boulder, CO.). The pellet was treated with 200 ll of 6.5% trichloro-
acetic acid and centrifuged at 6708g for 2 min to precipitate the
protein. This procedure was repeated twice. The ﬁnal pellet was
suspended in 1 ml of a medium containing 0.5% sodium dodecyl
sulfate, 0.5 mM ethylenediaminetetraacetic acid (EDTA), 0.5 M
tris(hydroxymethyl)aminomethane (Tris) pH 8.3, and 100 lM
DTNB. The absorbance was measured at 412 nm; glutathione was
used for calibration.
Mitochondrial assays
Oxygen consumption was monitored polarographically in the
standard medium in an oxygraph equipped with a Clark-type oxy-
gen electrode (Hansatech instruments, oxytherm electrode unit,
UK). The mitochondrial membrane potential was estimated spec-
troﬂuorimetrically using 10 lM safranine O as a probe at the
495/586 nm excitation/emission wavelength pair [26]. ROS/RNS
production was determined by monitoring the oxidation of dichlo-
rodihydroﬂuoresceindiacetate (H2DCFDA, 2 lM) (Molecular
Probes, Eugene) at the 503/528 nm excitation/emission wave-
length pair [27]. All ﬂuorimetric experiments were conducted in
a Model F-4500 Hitachi spectroﬂuorimeter (Tokyo, Japan). Mito-
chondrial swelling was estimated from the decrease in apparent
absorbance at 540 nm using a Model U-2910 Hitachi spectropho-
tometer [28].
Western blotting for cytochrome c
Cytochrome c released from mitochondria was assessed by
Western blotting. After incubation, harvested mitochondria were
resuspended in CelLytic™M (Sigma) lysis buffer for 2 min on ice
and centrifuged at 10000g for 5 min. The resulting supernatants
were subjected to 12% SDS–PAGE, transferred to a nitrocellulose
membrane and probed with antibodies against cytochrome c (BD
Pharmigen, puriﬁed mouse anti-cytochrome c) followed by horse-
radish peroxidase-coupled detection.
Statistical analysis
Statistical analysis was performed using two-way ANOVA and
assuming equality of variance with Bonferroni’s post hoc test for
pair-wise comparisons. Results with P < 0.05 were considered sta-
tistically signiﬁcant.
Results
Chemical aspects of[Ru(NO2)(bpy)2(4-pic)]
+(I)
The NO donor property of (I) was previously proposed based on
its vasodilator activity [29], and the involvement of OAT [19] in NO
release was suggested by our preliminary study on its stability.
The stability of nitrosyl ruthenium complexes of the type [RuL(b-
py)2(NO)]3+ (L = ligand) is pH dependent [30], similar to that
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this type of complex yields [Ru(NO2)(bpy)2L] in solutions with
pHP 5.0 [29,30] according to the equation bellow. The spectral
proﬁle of [Ru(NO)(bpy)2(4-pic)]3+ in an acidic solution (pH = 1.5)
shows strong absorption in 290 nm that has been assigned to the
intra ligand transition and a shoulder at 330 nm, indicated by the ar-
row at Fig. 1A, attributed to the metal–ligand charge transfer band
due to transition dp{Ru(II)}–p⁄(NO+). This assignment is in conformity
with molecular orbital description for similar nitrosyl ruthenium
complexes [29,30]. However, in neutral solutions (pH = 7.4), the
spectrum revealed the presence of coordinated nitrite, as indicated
by the arrow (b). Therefore, we assumed that at pH 7.4, [Ru(NO)(b-
py)2(4-pic)]3+ essentially generates (I) and that NO

2 is involved as
an intermediate in NO release from this complex (OATmechanism).Fig. 1. (A): Absorption spectra of (I) solubilized at acidic pH (a) and neutral pH (b)
in a standard medium consisting of 125 mM sucrose, 65 mM KCl and 10 mM
HEPES–KOH.(B) and (C): Direct determination by a selective electrode of the NO
released from 50 lM (I) in the presence (B) or absence (C) of succinate-energized
mitochondria (1 mg protein/ml) incubated in the standard medium; in (C): 50 lM
(I), 1 mM b-NADH and 20 lM NaNO2 were added at the beginning. Traces are
representative of three experiments. (D): Interaction of NADH with (I) assessed by
ﬂuorescence quenching and analyzed by a Stern–Volmer plot; insert: b-NADH
(1 mM) incubated in the standard medium in the presence of (I) at ﬁnal
concentrations of 1–25 lM. Experimental conditions are described in materials
and methods.½RuLðbpyÞ2ðNOÞ3þ þ 2OH 
Keq ½RuLðNO2ÞLðbpyÞ2þ þH2OInteraction of (I) with mitochondrial NADH induces NO release
Fig. 1B shows a continuous release of NO from (I) incubated
with mitochondria that were isolated from rat liver and energized
with the site II respiratory substrate succinate (+rotenone); mito-
chondria were probably involved in the release of NO because in
aqueous solution this release only occurs upon light irradiation
[30]. Fig. 1C shows the NO release from (I) when elicited by NADH
in the absence of mitochondria, suggesting that NADH oxidation
was involved in the release of NO as well. The NaNO2 was used
as a negative control for the OAT mechanism. In fact NaNO2 was
unable to produce NO either in the absence or presence of NADH.
These results indicate that NO release from (I) was mediated by the
oxidation of mitochondrial NADH via the OAT mechanism, which
renders NO binding to the complex labile. In an attempt to conﬁrm
the correlation between NO release from (I) and NADH oxidation
[18], we measured the intrinsic ﬂuorescence of b-NADH in the
presence of (I) (Fig. 1D, insert). In fact, the Stern–Volmer analysis
[31]resulted in KD = 9.0  103 in aqueous solution (Fig. 1D) and,
therefore, a 1:1 stoichiometric association between (I) and NADH.Effects of NO released from (I) on mitochondrial respiration
Fig. 2 shows the effects of (I) on the respiration of succinate-
energized mitochondria in the presence of ADP (phosphorylating,
state 3 respiration). After ADP was consumed, a basal respiration
condition was reached (state 4 respiration); in this condition, car-
bonyl cyanide m-chlorophenylhydrazone (CCCP) induced uncou-
pled respiration (VCCCP). The presence of (I) increased the state 4
respiration rate (V4) at relatively low concentrations: 20 and
50 lM (Fig. 2A and D); the presence of 20 lM (I) for 20 min re-
sulted in the same effect (Fig. 2B and D). Nevertheless, incubation
with 50 lM (I) for 20 min inhibited mitochondrial respiration, as
evidenced by a decrease in the state 3 respiration rate (V3) and
VCCCP (Fig. 2C and D); incubation with 80 and 100 lM (I) led to
the same effect (Fig. 2A and D). Therefore, (I) acted as a mitochon-
drial uncoupling agent at relatively low concentrations regardless
of the incubation time and as a respiratory chain inhibitor at higher
concentrations/incubation times. These effects resulted in a con-
centration-dependent decrease of the mitochondrial respiratory
control ratio (RCR) (Fig. 2E).Interaction of NO released from (I) with superoxide radicals
It is well established the basal generation of superoxide by
mitochondria and its rapid conversion to H2O2 by SOD. The inter-
action of NO released from (I) with large amount of superoxide
was assessed in presence of the xanthine/xanthine oxidase
(X/XO) reaction in order to guarantee an excess of the radical able
to react with the NO released. Fig. 3 shows that (I) decreased the
levels of superoxide generated by the X/XO reaction in the pres-
ence of succinate-energized mitochondria, in apparent association
with peroxynitrite yielded by the interaction of NO released from
(I) with this radical. Accordingly, the amount of NO available after
photo-irradiation of (I), monitored by a selective electrode (Fig. 3,
insert) markedly decreased the levels of superoxide generated by
the X/XO reaction, indicating that NO, indeed, interacted with
superoxide. Since superoxide is generated at the intra-matrix space
of mitochondria through respiratory chain complex I and III [32]
and NO is released from (I) through NADH oxidation, it is probable
that this reaction occurs mostly intramitochondrially.
Fig. 2. Effects of NO released from (I) on the respiration of succinate-energized mitochondria. Representative traces were monitored immediately after addition of (I) to
mitochondria (A) and after 20 min incubation (B) and (C). State 3 (V3), state 4 (V4) and uncoupled (VCCCP) respirations are shown in (D); respiratory control ratios (RCRs) are
shown in (E). Mitochondria (0.5 mg protein/ml) energized with 5 mM succinate (+2.5 lM rotenone) were incubated in the standard medium in the presence of 5 mM
phosphate with 0 (a), 20 (b), 50 (c), 80 (d) or 100 lM (e) (I) and pre-incubated for 20 min with 20 (f) or 50 (g) lM (I). For the V3 determination, 200 lMADP was added. V4 was
determined after the ADP was exhausted and VCCCP was determined after addition of the uncoupler CCCP (1 lM). Values are presented as mean ± SEM (n = 3), ⁄P < 0.05 vs.
control, #P < 0.05comparing the two incubation times.
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protein–thiol oxidation
Fig. 4A/4A-1 shows an increase of ROS/RNS levels in succinate-
energizedmitochondria incubatedwith(I) as indicated by oxidation
of the nonspeciﬁc probe H2DCFDA[27]; this increase was potenti-
ated by100 lM Ca2+(Fig. 4B/4B-1), which is in agreement with the
established property of this cation in stimulating ROS generationby the respiratory chain [32]. The presence of 2-(4-carboxy-
phenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO),
an NO scavenger, prevented this effect under both conditions. How-
ever, in the absence of Ca2+, the effect of (I) (at 100 lM) was only
slightly inhibited by the mitochondrial permeability transition
inhibitor cyclosporine A (CsA) (Fig. 4A/4A-1); in the presence of
Ca2+, a higher inhibition was observed (Fig. 4B/B-2). At the same
concentration range and under the same conditions in which (I)
Fig. 3. Interaction of NO released from (I) with superoxide radicals generated by
the xanthine/xanthine oxidase (X/XO) reaction in the presence of succinate-
energized mitochondria, assessed by NBT reduction as described in Materials and
methods. Bars represent mean ± SEM (n = 3). Insert: direct NO assessment in the
presence of 20 lM (I) after photo-irradiation in the standard medium, measured
using a diode laser operating at 447 nm (Colibri quantum Tec), with 12.4 mW
potency and 8.1 J-cm2 dose, in the presence or absence of X/XO.
Fig. 5. Effects of NO released from (I) on protein–thiol (–SH) oxidation in succinate-
energized mitochondria. Mitochondria (0.5 mg protein/ml) were incubated in the
standard medium with DTNB, which assesses free thiols, in the presence of (I), with
or without cPTIO (100 lM) and CsA (1 lM); experimental conditions are described
in Materials and methods. Values are presented as the mean ± SEM (n = 3) ⁄P < 0.05
vs. control.
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oxidation of mitochondrial membrane protein–thiols in a manner
that was inhibited by cPTIO but insensitive to inhibition by CsA
(Fig. 5).
Effects of NO released from (I) on mitochondrial swelling,
mitochondrial membrane potential and cytochrome c release
from mitochondria
Fig. 6A shows the induction of mitochondrial swelling by (I).
This swelling was only partially inhibited by CsA almost fully
inhibited by the thiol reagent N-ethylmaleimide (NEM) and fully
inhibited by cPTIO. A very similar pattern was observed for theFig. 4. Effects of NO released from (I) on ROS/RNS levels in succinate-energized mitoc
Mitochondria (0.5 mg protein/ml) were incubated with 2 lM H2DCFDA in the standard m
cPTIO (100 lM) and CsA (1 lM) pre-incubation, are indicated. Values are presented as t
represented in A-1 and B-1. ⁄P < 0.05 vs. control.mitochondrial membrane potential dissipation promoted by (I)
(Fig. 6B). The cytochrome c released from mitochondria incubated
with (I) was assessed by Western blotting analysis (Fig. 7A). An (I)-
induced increase of cytochrome c content in the mitochondrial
supernatant was revealed; this increase was not affected by CsA
but signiﬁcantly inhibited by NEM and cPTIO (Fig. 7A-1). The mito-
chondrial assays were also performed with the aqua-bound specie
cis-[Ru(H2O)(bpy)2(4-pic)]2+as a control (results not shown) and
didn’t show the effects observed in the presence of (I).Discussion
Nitrosyl ruthenium complexes are promising NO donor agents
with numerous advantages for the biologic applications of NO
[8,18,33,34]. The present work indicates that mitochondrial NADH
oxidation promotes NO release from the nitrosyl ruthenium com-
plex (I) in a manner mediated by NO2 formation (at neutral pH),
as in mammalian cells [20,21], followed by an OAT mechanism.
The slow rate of NO release from (I) observed after incubation withhondria, assessed by H2DCFDA oxidation as described in Materials and methods.
edium with 1 mM EGTA (A) or with 50 lM added Ca2+ (B); (I) additions, as well as
he mean ± SEM (n = 3) of ROS/RNS levels after 600 s, obtained from traces that are
Fig. 6. Effects of NO released from (I) on swelling (A) and membrane potential (B) in
succinate-energized mitochondria. (A): Mitochondria (0.5 mg protein/ml) were
incubated in the standard medium with (I), with or without cPTIO (100 lM), CsA
(1 lM) or NEM (20 lM) and energized with 5 mM succinate (+2.5 lM rotenone).
(B): Mitochondria (1 mg protein/ml) were incubated in the standard medium with
10 lM safranine O, 2.5 lM rotenone and (I) at the same conditions used for the
swelling assay; the reaction was initiated with 5 mM succinate. Traces are
representative of at least three experiments from different mitochondrial
preparations.
Fig. 7. Effects of NO released from (I) on cytochrome c release from succinate-
energized mitochondria. Mitochondria were incubated as described for the swelling
assay (Fig. 5A), centrifuged at 14000 rpm, and the supernatants were analyzed by
Western blotting as described in materials and methods.
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photo-irradiation suggests a high stability of (I) in a controlled sys-
tem like these organelles. Although some NO donor agents release
this species spontaneously, they can hazardously reach regions
that are not necessarily NO targets [30,35,36]. Thus (I) may be
advantageous as an NO donor agent due to its NO reservoir quality
in a reducing environment like that provided by mitochondria
through NADH. In this regard, a controlled NO release is beneﬁcial
for the organism, as has been observed during the prevention/de-
lay of cerebral vasospasm [37].
NO and its derivatives have multiple effects on mitochondria
which ultimately can lead to cell death [1,4,7]. While NO per se
can inhibit cytochrome c oxidase through a reversible process,
the rapid reaction between this radical and the superoxide gener-
ated by mitochondria yields RNS, mainly peroxynitrite, which can
irreversibly inhibit the mitochondrial respiratory chain [38]. Atrelatively high concentrations of (I) or long incubation times with
mitochondria, V3 and VCCCP decreased. Moreover, (I) promoted a
decrease in the amount of superoxide generated by the xanthine/
xanthine oxidase reaction and photo-irradiation of (I) in the pres-
ence of superoxide decreased the NO levels, indicating that, in fact,
the peroxynitrite produced by the interaction between NO and
superoxide could mediate the action of (I) on mitochondria. In this
regard, the oxidation of H2DCFDA incubated with (I) may reﬂect
the presence of peroxynitrite once this nonspeciﬁc probe is reac-
tive towards products of this species [27,39].
The mitochondrial permeability transition (MPT) is a well-doc-
umented phenomenon [40,41] that is typically associated with the
oxidation of mitochondrial membrane protein–thiols [42,43]. The
MPT results from the opening of permeability transition pores
(PTPs), which causes mitochondrial swelling in vitro; the process
is usually dependent on Ca2+ and sensitive to inhibition by CsA.
[44–48]. We demonstrated that (I) induces a Ca2+-independent
mitochondrial swelling that is only partially inhibited by CsA but
completely prevented by the thiol reagent NEM; this observation
is consistent with the ability of (I) to induce the oxidation of
protein–thiol groups. Indeed peroxynitrite can react directly with
protein–thiols to form sulfonic acids, which are readily trans-
formed to disulﬁdes (cross-linking) or higher thiol oxidation prod-
ucts [19,49]. A consequence of the oxidation of mitochondrial
membrane protein–thiols is a shift in the voltage-dependence of
PTPs, allowing them to open in association with conformational
protein changes; PTP opening, in turn, may be accompanied by
the release of cytochrome c from mitochondria, which has been
associated with cell death by necrosis or intrinsic pathway of apop-
tosis [40]. Although the proteins that must be oxidized/cross-
linked to open PTPs are still unknown, the ADP/ATP translocator
is probably involved [50]. In fact, it was previously reported that
both NO and peroxynitrite react with the ADP/ATP translocator
to induce mitochondrial membrane permeabilization [51].
The present results indicate that (I) release NO in a manner that
is mediated by mitochondrial NADH via an OAT mechanism. The
NO released from (I) uncoupled mitochondria at low concentra-
tions/incubation times and inhibited the respiratory chain at high
concentrations/incubation times. In the presence of ROS generated
by mitochondria, which increases in the presence of Ca2+, NO gave
rise to peroxynitrite, which, in turn, inhibited the respiratory chain
and oxidized membrane protein–thiols to elicit a Ca2+-independent
mitochondrial permeability transition that was only partially
inhibited by CsA; these actions correlated with the release of cyto-
chrome c from mitochondria. These mitochondrial events are typ-
ically involved in cell necrosis and/or apoptosis [52,53], and
consequently present the potential to kill tumor cells. Changes in
the membrane potential of mitochondria in tumor cells due to
low oxygen availability and low Complex I activity could increase
the organelle’s levels of NADH [54,55]. This metabolic peculiarity
of these cells may render them preferential targets for NO release
from (I)/analogs and cause mitochondria-mediated cell death. In
fact, a ruthenium complex analog of (I) was toxic to the C6 astro-
cytoma cell line but not to primary rat astrocytes [56]. In relation
to our [18] and other previous studies the present data adds the
following new information on the biologic action of the nitrosyl
ruthenium complexes: (I) potential release of NO in a manner that
is mediated by mitochondrial NADH via an OAT mechanism; (ii)
characterization of a Ca2+-independent mitochondrial permeability
transition process in association with oxidized membrane protein–
thiols; and (iii) correlation with the release of cytochrome c from
isolated mitochondria and so, potential action regarding the intrin-
sic apoptotic pathway. Although these studies were performed in
an extreme in vitro system, they denote a potential speciﬁc action
of (I) and analogs against tumor cells via mitochondria-mediated
processes. Studies of these processes in tumor cell lineage exposed
180 F.P. Rodrigues et al. / Nitric Oxide 26 (2012) 174–181to (I) are being conducted both to highlight this potential and to
characterize its action in this setting.Acknowledgments
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